Neil Chatterji
Stock Analyst at B. Riley Securities
(2.49)
# 2,421
Out of 5,012 analysts
19
Total ratings
41.18%
Success rate
19.24%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $20 → $28 | $26.39 | +6.10% | 4 | Apr 25, 2025 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $17.95 | -27.58% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $40.43 | +23.67% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $1.57 | +377.71% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $20.17 | -10.76% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $3.93 | +14.50% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $1.72 | +103.49% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $3.18 | +72.96% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $2.50 | +280.00% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Apr 25, 2025
Maintains: Buy
Price Target: $20 → $28
Current: $26.39
Upside: +6.10%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $17.95
Upside: -27.58%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $40.43
Upside: +23.67%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $1.57
Upside: +377.71%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $20.17
Upside: -10.76%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $3.93
Upside: +14.50%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $1.72
Upside: +103.49%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $3.18
Upside: +72.96%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $2.50
Upside: +280.00%